Arbitrator Allows Gen-Probe to Join Digene and Roche License Dispute | GenomeWeb
NEW YORK (GenomeWeb News) — An arbitration panel overseeing a legal skirmish between Digene and Roche has allowed Gen-Probe to participate in the proceeding, Digene said today.
In the proceeding, Digene hopes to prove that a February 2005 supply and license agreement between Roche and Gen-Probe was an illegal sublicense under a 1990 cross-license agreement, the rights to which are held by Digene and Roche.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.